Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Cll-Ibrutinib'

Cll-Ibrutinib published presentations and documents on DocSlides.

Update on chronic lymphocytic leukemia (CLL) treatment
Update on chronic lymphocytic leukemia (CLL) treatment
by joy
Dr Mona Yuklea. Hematology Department, Meir Hospi...
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
by carny
Mallaig. Sprinkling Song . Spirit of God, come dw...
Clonal Evolution in CLL:
Clonal Evolution in CLL:
by karlyn-bohler
Impact . on t. iming . of . therapy. Nicholas Chi...
Dr.V.Shanthi Associate Professor , Pathology
Dr.V.Shanthi Associate Professor , Pathology
by luna
Sri . Venkateswara. Institute of Medical Sciences...
Hima Darapu, MD Princeton Baptist Medical Center
Hima Darapu, MD Princeton Baptist Medical Center
by felicity
Baptist Health systems Alabama. Baseline Flow Cyto...
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
by erica
Table1ClinicalandimagingcharacteristicsofBcellindo...
Reproducible diagnosis of
Reproducible diagnosis of
by davis
Title: Chronic Lymphocytic Leukemia by flow cyto...
Chronic Lymphocytic
Chronic Lymphocytic
by caitlin
A Guide for Being diagnosed with Chronic Lymphocy...
PATIENT EDUCATION
PATIENT EDUCATION
by brooke
Introduction Chronic lymphocytic leukemia (CLL) is...
Presenter : CR 周益聖
Presenter : CR 周益聖
by CottonTails
Supervisor: VS . 曾主任. Cell 152, 714–726, F...
Comparison between Time-
Comparison between Time-
by LifeOfTheParty
Limited,Venetoclax. -Based and Continuous Bruton ....
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
by Tigerwoods
Mehrdad. . Payandeh. Department of Hematology and...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
Using DNA copy number aberrations to
Using DNA copy number aberrations to
by pamela
identify candidate drivers of . carcinogenesis in ...
C hronic lymphocytic
C hronic lymphocytic
by della
leukemia. Magdalena Olszewska-Szopa. Definition. C...
www.society -for- hematopathology.org
www.society -for- hematopathology.org
by yvonne
SH2021-XX . Marrow involvement by clonally-related...
Curriculum Guide 2012 French I
Curriculum Guide 2012 French I
by audrey
Unit Objectives Approx 15 week per unit New Essent...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
Interesting case conference
Interesting case conference
by natalia-silvester
Mary-Margaret Allen, MD. February 24, 2015. 58 . ...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Making Sense of Novel Prognostics: NOTCH1, SF3B1
Making Sense of Novel Prognostics: NOTCH1, SF3B1
by olivia-moreira
Jennifer R Brown, MD PhD. Director, CLL Center. D...
Personalized Therapy in Relapsed or Refractory CLL
Personalized Therapy in Relapsed or Refractory CLL
by kittie-lecroy
IWCLL Criteria for Treating CLL. Other Considerat...
chronic lymphocytic leukemia
chronic lymphocytic leukemia
by test
is the most common type of . leukemia. . . CLL in...
Case 2012-09
Case 2012-09
by tawny-fly
Diagnostic Slide Session. AANP - Annual Meeting. ...
Implementing Best Practices in Chronic Lymphocytic Leukemia
Implementing Best Practices in Chronic Lymphocytic Leukemia
by myesha-ticknor
CLL/SLL. Use of Markers in Nonclinical Trial Prac...
Case Study Interpretation
Case Study Interpretation
by lindy-dunigan
Spring 2010. Clinical history. A 62 year old man ...
CCVPN Support for Intent
CCVPN Support for Intent
by audrey
2. Timeline of CCVPN and its relation with Net Sli...
Synthesis and biological evaluation of new
Synthesis and biological evaluation of new
by caroline
N. -substituted 9-nitro-12,14-dioxo-9,10-dihydro-9...
Bill Kobren Director, Logistics & Sustainment Center
Bill Kobren Director, Logistics & Sustainment Center
by danya
Defense Acquisition University. E-mail: bill.kobre...
B‐cell prolymphocytic
B‐cell prolymphocytic
by angelina
. leukaemia. CLL-related conditions. Monoclonal B-...
What is the difference between LGL
What is the difference between LGL
by bethany
leukemia and chronic lymphocytic l eukemia (C...
Dr. Maher jabbar salih
Dr. Maher jabbar salih
by Vikingwarrior
. Medical oncologist . Al-. basrah. . onco. . Cen...
Pooled Analysis of Cardiovascular Events From Clinical Trials Evaluating
Pooled Analysis of Cardiovascular Events From Clinical Trials Evaluating
by LoneWolf
Acalabrutinib. Monotherapy in Patients With Chron...
EHA Stockholm 2018 Deepak Mannari
EHA Stockholm 2018 Deepak Mannari
by riley
Advances in AML. Doses of . Dano. , . Cladrabine. ...
Chronic Leukemia and
Chronic Leukemia and
by ash
Multiple Myeloma . Chronic Leuke...
How does CLA (carry look-ahead adder) work?
How does CLA (carry look-ahead adder) work?
by evans
Wei-. jen. Hsu. TA for EE457 at USC, Fall 2004. M...
IncompleteDJHrearrangementsoftheIgHgenearefrequentinmultiplemyelomapat
IncompleteDJHrearrangementsoftheIgHgenearefrequentinmultiplemyelomapat
by christina
CorrespondenceProfessorJSanMiguelHematologyDepartm...
ProcNatlAcadSciUSAVol80pp23412345April1983ImmunologyAutologousandallo
ProcNatlAcadSciUSAVol80pp23412345April1983ImmunologyAutologousandallo
by morton
ProcNatlAcadSciUSA801983ofpenicillinand100tugofstr...
SIgENuliCellNonHodgkinsLymphomasMultiparametricDeterminationofthei
SIgENuliCellNonHodgkinsLymphomasMultiparametricDeterminationofthei
by genevieve
Vol120No3NULL-CELLLYMPHOMAS357sionsofneoplasticcel...
Primer on Kinase Inhibitors
Primer on Kinase Inhibitors
by giovanna-bartolotta
Richard R. Furman. Directory, CLL Research Center...